Impact of MEditerranean Diet, Inflammation and Microbiome After an Acute Coronary Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-14

Study Completion Date

2022-08-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the MEDIMACS project, the investigators will use a randomized clinical-trial design to address the effects of mediterranean diet on atherosclerotic plaque vulnerability and coronary endothelial function in order to decipher complex interplays between diet, microbiome, immunological and metabolic responses and coronary atherosclerosis. The investigators will focus on patients after an episode of acute coronary syndrome and use state-of-the-art techniques to address atherosclerotic plaque composition and coronary endothelial function. A number of different -omic approaches will be used to address effector pathways. The insights provided by this study will allow identifying potential new dietary, microbiota and/or metabolic targets for the treatment of atherosclerosis

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An Intervention Study to Assess the Effect of the Mediterranean Diet on the Plasma Fatty Acid Profile

NCT02578329

Coronary Artery Disease

UNKNOWN NA

Effects of Mediterranean Diet Intervention in Diabetic Heart Disease

NCT03757845

Diabetes Complications Cardiovascular Diseases

TERMINATED NA

Investigation of Microbiome-Derived Metabolite Production in Response to a Mediterranean Diet

NCT03783260

Food Habits

COMPLETED NA

Effects of the Mediterranean Diet on Cardiovascular Risk Profile in Men and Women

NCT01293344

Cardiovascular Diseases

COMPLETED NA

Microbiome-Tailored Food Products Based On Typical Mediterranean Diet Components

NCT05451992

Microbiota Overweight and Obesity Metabolic Complication

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Coronary atherosclerosis is a leading cause of mortality and disability worldwide. Continuous efforts are needed to improve secondary prevention and understand the mechanism underlying disease progression. Based on primary prevention trials, a potential benefit of the Mediterranean diet after an acute coronary syndrome can be anticipated. The integrated microbiome-mediated/ immunologic and metabolic pathways by which the Mediterranean diet modifies cardiovascular risk remain mostly unknown. Intestinal and oral dysbiosis is involved in the pathogenesis of atherosclerosis and microbiome dynamics may account for some of the observed benefits of Mediterranean diet. The first objective of the trial is to evaluate the effects of a well-controlled Mediterranean diet intervention on atherosclerotic plaque vulnerability and coronary endothelial dysfunction after an episode of acute coronary syndrome. The second objective is to decipher the interplays among diet, microbiota, immunity and metabolism responsible for the observed effects. The investigators propose a randomized mechanistic clinical trial, using state-of-the-art efficacy read-outs. The multidisciplinary consortium includes highly experienced cardiologists, nutritionists and experts in translational research in immunology, microbiomics, genomics, proteomics, metabolomics and metagenomics. This study will provide valuable insights to identify potential microbiome therapeutic targets for coronary artery disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Intervention Group: High intensity Mediterranean diet in secondary prevention after acute coronary syndrome. Control Group: recommendation of a standard of care, standard Mediterranean diet. Duration of the intervention per participant: 12 months. Follow-up period per participant: 12 months.

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Non-intervention or MedDiet intensive intervention group assignment will be made through an automated system. Each patient will be assigned a patient identification number that should appear on all eCRF pages (electronic "case report"), source documents and laboratory data. All researchers involved in the measurement of data, analysis and allocation of results will be blind. The MedDiet intensive intervention will be blind to the evaluation of the endpoints (the research team in charge of the measurement, analysis and awarding of the results will be blind). The samples will be coded and anonymously analyzed by each research team

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

In patients allocated to the control group, the currently used Spanish Mediterranean diet will be recommended as part of a standard high-quality secondary prevention program, where the patient is invited to participate in a single 45 minute nutritional educational group session. Interventions: Microbiota analysis, Immunological analysis, Proteome analysis, Metabolome analysis, Clinical evaluation

Group Type EXPERIMENTAL

Microbiota analysis

Intervention Type OTHER

From the feces and oral cavity samples, the DNA of the microbiota will be extracted using specific extraction kits and the microbiome will be analyzed through the study of 16S ribosomal RNA amplicons.

Immunological analysis

Intervention Type OTHER

A study of immunological cell populations, inmunogenetics and cytokines will be carried out from fresh blood samples using antibody panels and flow cytometry

Proteome analysis

Intervention Type OTHER

A study of host and microbiota proteome will be carried out from samples using mass spectrometry

Metabolome analysis

Intervention Type OTHER

A study of host and microbiota metabolome will be carried out from samples using MS-based as well as NMR-based methods

Clinical evaluation

Intervention Type OTHER

Clinical evaluation including hemostasis and biochemical studies

Diet evaluation

Intervention Type OTHER

Biochemical analysis and questionaries for diet adherence and exercise registration

High-intensity MedDiet

Patients allocated to the interventional group will be individually evaluated by a dietitian and will participate in dedicated individual and group sessions at baseline, and at 3, 6, 9 and 12 months. In the interventional group, a personalized MedDiet will assess chemical and nutritional composition and total energy intake will be adapted to participant's weight, age, and requirements, and the dietitian's tailored advice to his/her individual needs. A 14-item dietary screen for adherence to the Mediterranean diet will be used to personalize the intervention and negotiate dietary changes. Furthermore, free virgin olive oil, recipes, shopping list and designed weekly menus will be provided to maximize the differences between groups. Interventions: MedDiet, Microbiota analysis, Immunological analysis, Proteome analysis, Metabolome analysis, Clinical evaluation, Diet evaluation

Group Type EXPERIMENTAL

Microbiota analysis

Intervention Type OTHER

From the feces and oral cavity samples, the DNA of the microbiota will be extracted using specific extraction kits and the microbiome will be analyzed through the study of 16S ribosomal RNA amplicons.

Immunological analysis

Intervention Type OTHER

A study of immunological cell populations, inmunogenetics and cytokines will be carried out from fresh blood samples using antibody panels and flow cytometry

Proteome analysis

Intervention Type OTHER

A study of host and microbiota proteome will be carried out from samples using mass spectrometry

Metabolome analysis

Intervention Type OTHER

A study of host and microbiota metabolome will be carried out from samples using MS-based as well as NMR-based methods

Clinical evaluation

Intervention Type OTHER

Clinical evaluation including hemostasis and biochemical studies

Diet evaluation

Intervention Type OTHER

Biochemical analysis and questionaries for diet adherence and exercise registration

MedDiet

Intervention Type OTHER

The high-intensity Mediterranean diet will include the promotion of the following: a) abundant use of olive oil (\>40 g/d) for cooking and dressing dishes; b) consumption of \>2 daily servings of vegetables; c) \>2-3 daily serving of fresh fruits; d) \>3 weekly servings of legumes; e) \>3 weekly servings of fish or seafood; f) \>1 weekly serving of nuts or seeds; g) select white meats instead of red meats or processed meats; and h) cook regularly with tomato, garlic and onion adding or no other aromatic herbs, and dress vegetables, pasta, rice and other dishes with tomato, garlic and onion adding or no other aromatic herbs. Two main meals per day should be eaten (seated at a table, lasting more than 20 minutes). A recommendation to drink a glass of wine per day during meals is given. Limited consumption is advised for cured ham, red meat, chocolate, cured or fatty cheeses

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Microbiota analysis

From the feces and oral cavity samples, the DNA of the microbiota will be extracted using specific extraction kits and the microbiome will be analyzed through the study of 16S ribosomal RNA amplicons.

Intervention Type OTHER

Immunological analysis

A study of immunological cell populations, inmunogenetics and cytokines will be carried out from fresh blood samples using antibody panels and flow cytometry

Intervention Type OTHER

Proteome analysis

A study of host and microbiota proteome will be carried out from samples using mass spectrometry

Intervention Type OTHER

Metabolome analysis

A study of host and microbiota metabolome will be carried out from samples using MS-based as well as NMR-based methods

Intervention Type OTHER

Clinical evaluation

Clinical evaluation including hemostasis and biochemical studies

Intervention Type OTHER

Diet evaluation

Biochemical analysis and questionaries for diet adherence and exercise registration

Intervention Type OTHER

MedDiet

The high-intensity Mediterranean diet will include the promotion of the following: a) abundant use of olive oil (\>40 g/d) for cooking and dressing dishes; b) consumption of \>2 daily servings of vegetables; c) \>2-3 daily serving of fresh fruits; d) \>3 weekly servings of legumes; e) \>3 weekly servings of fish or seafood; f) \>1 weekly serving of nuts or seeds; g) select white meats instead of red meats or processed meats; and h) cook regularly with tomato, garlic and onion adding or no other aromatic herbs, and dress vegetables, pasta, rice and other dishes with tomato, garlic and onion adding or no other aromatic herbs. Two main meals per day should be eaten (seated at a table, lasting more than 20 minutes). A recommendation to drink a glass of wine per day during meals is given. Limited consumption is advised for cured ham, red meat, chocolate, cured or fatty cheeses

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients undergoing cardiac catheterization for an acute coronary syndrome.
* At least 1 non-causal lesion in a coronary segment with a stenosis diameter between 40-70% that will not be submitted to intervention during the revascularization procedure.
* Disposition and possibility to modify the diet.
* With the ability to track and answer questionnaires.
* Signature of informed consent for the study

Exclusion Criteria

* TIMI score \<3 in the injury
* Reference lesion with diameter \<2.0 mm
* LV ejection fraction (EF) less than 45%.
* Active systemic infection
* Active periodontal disease
* Chronic inflammatory disease
* Active treatment with corticosteroids or immunomodulators
* Renal insufficiency with glomerular filtration less than 30 mL / min
* Severe hepatic insufficiency (liver cirrhosis in Child B or C stages).
* Comorbidity with life expectancy of less than one year

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No